Tonya Charise Phillips, LCSW-C,LCADC | |
2464 85th Medical Bn Avenue, Aberdeen Proving Ground, MD 20755 | |
(301) 677-7188 | |
(301) 677-5416 |
Full Name | Tonya Charise Phillips |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 2464 85th Medical Bn Avenue, Aberdeen Proving Ground, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134438856 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | LCA1814 (Maryland) | Secondary |
1041C0700X | Social Worker - Clinical | 14364 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tonya Charise Phillips, LCSW-C,LCADC 2464 85th Medical Bn Avenue, Aberdeen Proving Ground, MD 20755 Ph: (301) 677-7188 | Tonya Charise Phillips, LCSW-C,LCADC 2464 85th Medical Bn Avenue, Aberdeen Proving Ground, MD 20755 Ph: (301) 677-7188 |
News Archive
Failure to curb our deficits and reform unsustainable entitlement spending means passing greater debt burdens on to future generations. Democrats and Republicans have the opportunity to reverse this trend and claim credit. ... Sadly, the deal struck this week in Congress maintains the trend of $1 trillion deficits for at least another year while continuing to ensure that federal health care spending a generation from now will be untenable.
Although non-radiologist physicians have contributed to the widespread use of point-of-care (POC) ultrasound, radiologists remain the primary users, according to a study in the November issue of the Journal of the American College of Radiology.
The University of Minnesota's Institute for Mathematics and its Applications (IMA) has been awarded a $20.5-million National Science Foundation (NSF) renewal grant over the next five years. The renewal grant continues the IMA's tradition as one of the nation's top math institutes in terms of funding.
Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA's test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients.
› Verified 5 days ago